Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name TUG1
   Synonyms TUG1, LINC00080, NCRNA00080, TI-227H, FLJ20618
   Region GRCh38_22:30969245-30979395    Sequence
   Ensembl ENSG00000253352
   RefSeq NR_002323
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name oral squamous cell carcinoma
   ICD-0-3 C06.9  M8070/3
   Methods qPCR, Western blot, Luciferase reporter assay
   Sample Both tumors, OSCC cell lines (HN4, HN6, SCC-25, CAL-27, NHOK)
   Expression Pattern up-regulated
   Function Description

In conclusion, our data revealed that TUG1 confers oncogenic function in OSCC and TUG1/miR-219/FMNL2 axis may be a novel therapeutic strategy in this disease.Clinically, the expression of TUG1 and FMNL2 were increased, but miR-219 was decreased in primary tumors compared to non-tumor tissues. Both the upregulated TUG1, and FMNL2 and the downregulated miR-219 was associated with advanced stage of OSCC and poor overall survival.Increasing evidences indicated that the dysregulated lncRNAs and miRNAs were correlated with tumor progression and cancer-related cellular process, including proliferation, apoptosis, migration, and invasion.

   Pubmed ID 28979812
   Year 2017
   Title Long non-coding RNA TUG1 promotes progression of oral squamous cell carcinoma through upregulating FMNL2 by sponging miR-219
   External Links
   Links for  TUG1 GenBank       HGNC       lncrnadb       Noncode
   Links for  oral squamous cell carcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.